On December 31, 2012, Mr. Geoffrey Wolf was elected to the Board of Directors of Lightlake Therapeutics Inc. Mr. Wolf spent 35 years of his career in international commerce and industry, working closely with companies dealing with minerals, pharmaceuticals, metals, mining, oil and gas, hospitality and real estate.
Opiant Pharmaceuticals, Inc.
Equities
OPNT
US6837501039
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+20.17% | 126B | |
+24.67% | 118B | |
+25.04% | 27.87B | |
-17.74% | 20.95B | |
-15.29% | 16.92B | |
-15.21% | 16.18B | |
+11.91% | 14.84B | |
-47.10% | 14.79B | |
+54.50% | 14.08B |